公司资料
10x Genomics 股价、新闻与催化剂
- 股票代码:
- TXG
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
57.99 USD (+3.39%)
收盘价
最后更新: 2026年8月17日
3.9B USD
市值
股价为何变动
As of Aug 17, 2026, TXG closed up 3.39% at $57.99. No new same-company headline was identified in the current news window.
公司概览
业务概览
10x Genomics is a life sciences tools company focused on single-cell and spatial biology technologies. Its products help researchers study biology at high resolution and support discovery across genomics and translational research.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, 10x Genomics has a global footprint in research tools. It sits in the biotech infrastructure layer rather than therapeutics.
商业模式特征
The company generates revenue from instruments, consumables, and workflow technologies used in genomics research. Investors watch academic and biopharma spending, product adoption, and the pace of platform utilization.
生物医药行业定位
10x Genomics is one of the most important tools names in modern biology because it powers discovery across the life sciences. It is not a drug company, but it is highly relevant to biotech research spending.
未来催化剂
- 10x Genomics’ catalysts are Xenium adoption, Chromium demand, and any evidence that consumables recovery is finally broadening. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。